慢性阻塞性肺疾病患者因急性呼吸症状加重住院时肺栓塞的患病率
这项在法国7家医院开展的多中心横断面研究,纳入740例因急性呼吸症状加重住院的COPD患者,入院48小时内按日内瓦评分、D-二聚体和CTPA加下肢加压超声的预设流程诊断肺栓塞,并随访3个月。结果48小时内肺栓塞患病率为5.9%(95%CI 4.5%-7.9%),入院时无静脉血栓栓塞且未抗凝的670例患者随访期肺栓塞发生率为0.7%(95%CI 0.3%-1.7%)。入院时有静脉血栓栓塞者3个月死亡率25.9%,显著高于无静脉血栓栓塞者的5.2%。提示该人群肺栓塞并非罕见,但系统筛查的价值尚需进一步研究。
要点
- 因急性呼吸症状加重住院的COPD患者中,入院48小时内按预设流程确诊肺栓塞者占5.9%(44/740,95%CI 4.5%-7.9%)。
- 临床未疑似肺栓塞的441例患者中静脉血栓栓塞患病率仍达4.3%(95%CI 2.8%-6.6%),提示不能仅凭低临床怀疑排除。
- 入院时存在静脉血栓栓塞者3个月死亡率25.9%(14/54),显著高于无静脉血栓栓塞者的5.2%(36/686),风险差20.7%。
- 入院时无静脉血栓栓塞且未抗凝的670例患者,3个月随访新发肺栓塞仅0.7%(5例),其中3例死于肺栓塞。
- 总体3个月死亡率为6.8%(50/740,95%CI 5.2%-8.8%)。
适用人群与场景
- 因急性呼吸症状加重住院的COPD患者,来自法国7家医院,2014年1月至2017年5月招募,平均年龄68.2岁(SD 10.9),女性274例(37.0%)。
诊断标准与关键阈值
- 肺栓塞诊断采用预设流程:基于日内瓦评分、D-二聚体水平、螺旋CT肺动脉造影加下肢加压超声,于入院48小时内完成。
处置流程与药物剂量
- 原文未提及具体治疗药物、剂量或抗凝方案。
红旗征与不能漏的情况
- 入院时存在静脉血栓栓塞的患者3个月死亡率25.9%(14/54),显著高于无静脉血栓栓塞者的5.2%(36/686),风险差20.7%(95%CI 10.7%-33.8%,P<.001)。
- 临床未疑似肺栓塞的患者中静脉血栓栓塞患病率仍为4.3%(95%CI 2.8%-6.6%),需警惕漏诊。
研究设计与关键结果
- 多中心横断面研究,前瞻性随访,纳入740例因急性呼吸症状加重住院的COPD患者,来自法国7家医院。
- 主要终点:入院48小时内确诊肺栓塞44例,患病率5.9%(95%CI 4.5%-7.9%)。
- 关键次要终点:入院时无静脉血栓栓塞且未抗凝的670例患者中,3个月随访新发肺栓塞5例(0.7%,95%CI 0.3%-1.7%),其中3例死亡与肺栓塞相关。
- 入院时静脉血栓栓塞总患病率为11.7%(95%CI 8.6%-15.9%)在临床疑似肺栓塞者(n=299)中,4.3%(95%CI 2.8%-6.6%)在临床未疑似者(n=441)中。
- 总体3个月死亡率6.8%(50/740,95%CI 5.2%-8.8%)。
证据类型、等级与局限
- 证据类型:多中心横断面研究,前瞻性随访。
- 局限性:原文未明确报告证据等级;研究设计为观察性研究,未评估系统筛查的干预效果,作者指出需进一步研究系统筛查肺栓塞在该人群中的作用。
对床旁实践的改变
- 对于因急性呼吸症状加重住院的COPD患者,应认识到肺栓塞患病率约5.9%,即使临床未疑似肺栓塞,静脉血栓栓塞患病率仍达4.3%,需保持警惕。
- 临床疑似肺栓塞的患者静脉血栓栓塞患病率更高(11.7%),应积极按预设诊断流程评估。
- 入院时存在静脉血栓栓塞与3个月死亡率显著升高相关(25.9% vs 5.2%),提示早期识别的重要性。
- 原文未提及系统筛查的推荐,作者仅指出需进一步研究其可能作用,因此不能据此常规推荐对所有COPD急性加重患者进行系统筛查。
指南或共识出处
- 原文未提及指南或共识名称;研究发表于JAMA。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The prevalence of pulmonary embolism in patients with chronic obstructive pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain.
OBJECTIVE: To determine the prevalence of pulmonary embolism in patients with COPD admitted to the hospital for acutely worsening respiratory symptoms.
DESIGN, SETTING, AND PARTICIPANTS: Multicenter cross-sectional study with prospective follow-up conducted in 7 French hospitals. A predefined pulmonary embolism diagnostic algorithm based on Geneva score, D-dimer levels, and spiral computed tomographic pulmonary angiography plus leg compression ultrasound was applied within 48 hours of admission; all patients had 3-month follow-up. Patients were recruited from January 2014 to May 2017 and the final date of follow-up was August 22, 2017.
EXPOSURES: Acutely worsening respiratory symptoms in patients with COPD.
MAIN OUTCOMES AND MEASURES: The primary outcome was pulmonary embolism diagnosed within 48 hours of admission. Key secondary outcome was pulmonary embolism during a 3-month follow-up among patients deemed not to have venous thromboembolism at admission and who did not receive anticoagulant treatment. Other outcomes were venous thromboembolism (pulmonary embolism and/or deep vein thrombosis) at admission and during follow-up, and 3-month mortality, whether venous thromboembolism was clinically suspected or not.
RESULTS: Among 740 included patients (mean age, 68.2 years [SD, 10.9 years]; 274 women [37.0%]), pulmonary embolism was confirmed within 48 hours of admission in 44 patients (5.9%; 95% CI, 4.5%-7.9%). Among the 670 patients deemed not to have venous thromboembolism at admission and who did not receive anticoagulation, pulmonary embolism occurred in 5 patients (0.7%; 95% CI, 0.3%-1.7%) during follow-up, including 3 deaths related to pulmonary embolism. The overall 3-month mortality rate was 6.8% (50 of 740; 95% CI, 5.2%-8.8%). The proportion of patients who died during follow-up was higher among those with venous thromboembolism at admission than the proportion of those without it at admission (14 [25.9%] of 54 patients vs 36 [5.2%] of 686; risk difference, 20.7%, 95% CI, 10.7%-33.8%; P < .001). The prevalence of venous thromboembolism was 11.7% (95% CI, 8.6%-15.9%) among patients in whom pulmonary embolism was suspected (n = 299) and was 4.3% (95% CI, 2.8%-6.6%) among those in whom pulmonary embolism was not suspected (n = 441).
CONCLUSIONS AND RELEVANCE: Among patients with chronic obstructive pulmonary disease admitted to the hospital with an acute worsening of respiratory symptoms, pulmonary embolism was detected in 5.9% of patients using a predefined diagnostic algorithm. Further research is needed to understand the possible role of systematic screening for pulmonary embolism in this patient population.
参考来源
- Couturaud F, Bertoletti L, Pastre J, et al. Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. JAMA. 2021. PMID: 33399840. doi:10.1001/jama.2020.23567
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。